Cargando…
GAS6‐expressing and self‐sustaining cancer cells in 3D spheroids activate the PDK‐RSK‐mTOR pathway for survival and drug resistance
AXL receptor tyrosine kinase (RTK) inhibition presents a promising therapeutic strategy for aggressive tumor subtypes, as AXL signaling is upregulated in many cancers resistant to first‐line treatments. Furthermore, the AXL ligand growth arrest‐specific gene 6 (GAS6) has recently been linked to canc...
Autores principales: | Baumann, Christine, Ullrich, Axel, Torka, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623821/ https://www.ncbi.nlm.nih.gov/pubmed/28675785 http://dx.doi.org/10.1002/1878-0261.12109 |
Ejemplares similares
-
The PDK1–Rsk Signaling Pathway Controls Langerhans Cell Proliferation and Patterning
por: Zaru, Rossana, et al.
Publicado: (2015) -
mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancer
por: Kumari, Anju, et al.
Publicado: (2023) -
PDK1/mTOR Signaling in Myeloid Cells Differentially Regulates the Early and Late Stages of Sepsis
por: Du, Juan, et al.
Publicado: (2020) -
PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8(+) T cells
por: Finlay, David K., et al.
Publicado: (2012) -
PDK1-mTOR signaling pathway inhibitors reduce cell proliferation in MK2206 resistant neuroblastoma cells
por: Qi, Lei, et al.
Publicado: (2015)